These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2772968)

  • 1. The effects of infusions of ring-A-reduced derivatives of aldosterone on the antinatriuretic and kaliuretic actions of aldosterone.
    Morris DJ; Souness GW; Saccoccio NA; Harnik M
    Steroids; 1989; 53(1-2):21-36. PubMed ID: 2772968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinatriuretic and kaliuretic activities of the reduced derivatives of aldosterone.
    Kenyon CJ; Brem AS; McDermott MJ; Deconti GA; Latif SA; Morris DJ
    Endocrinology; 1983 May; 112(5):1852-6. PubMed ID: 6403339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of antimineralocorticoids on synthesis of aldosterone metabolites in target tissues.
    Morris DJ; McDermott MJ; Freiberger M; Latif SA; Pacholski M; Brem AS
    J Steroid Biochem; 1986 Jan; 24(1):341-4. PubMed ID: 3702416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid inhibition of mineralocorticoid action in the rat.
    Kenyon CJ; Saccoccio NA; Morris DJ
    Clin Sci (Lond); 1984 Sep; 67(3):329-35. PubMed ID: 6380888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic synthesis of 3H-labeled Ring-A reduced metabolites of aldosterone and their separation by high pressure liquid chromatography.
    Latif SA; Camara P; Rosen MP; Morris DJ
    Steroids; 1987 Jun; 49(6):589-600. PubMed ID: 3453565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of the licorice derivative, glycyrrhetinic acid, on hepatic 3 alpha- and 3 beta-hydroxysteroid dehydrogenases and 5 alpha- and 5 beta-reductase pathways of metabolism of aldosterone in male rats.
    Latif SA; Conca TJ; Morris DJ
    Steroids; 1990 Feb; 55(2):52-8. PubMed ID: 2326827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineralocorticoid and renal receptor binding activity of 21-deoxyaldosterone.
    Koshida H; Miyamori I; Soma R; Matsubara T; Ikeda M; Takeda R; Nakamura S; Kiuchi F; Tsuda Y
    Endocrinology; 1990 Mar; 126(3):1410-5. PubMed ID: 2155101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5 alpha-Dihydro-11-deoxycorticosterone as a mineralocorticoid agonist and antagonist: evidence for a weak mineralocorticoid as an antagonist of potent mineralocorticoids.
    Sekihara H; Yazaki Y
    J Steroid Biochem Mol Biol; 1993 Apr; 45(4):235-8. PubMed ID: 8499332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal receptor-binding activity of reduced metabolites of aldosterone: evidence for a mineralocorticoid effect outside of the classic aldosterone receptor system.
    Gomez-Sanchez CE; Smith JS; Ferris MW; Gomez-Sanchez EP
    Endocrinology; 1984 Aug; 115(2):712-5. PubMed ID: 6086276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid activity of 19-hydroxyaldosterone, 19-nor-aldosterone, and 3 beta-hydroxy-delta 5-aldosterone: relative potencies measured in two bioassay systems.
    Morris DJ; Brem AS; Saccoccio NA; Pacholski M; Harnik M
    Endocrinology; 1986 Jun; 118(6):2505-9. PubMed ID: 3084221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sheep renal potassium excretion: efferent kaliuretic regulatory factors.
    Rabinowitz L; Sarason RL; Yamauchi H
    Am J Physiol; 1984 Sep; 247(3 Pt 2):F520-6. PubMed ID: 6476127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary sodium excretion is the main determinant of mineralocorticoid excretion rates in patients with chronic kidney disease.
    McQuarrie EP; Freel EM; Mark PB; Fraser R; Connell JM; Jardine AG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1526-32. PubMed ID: 23413088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New mineralocorticoids: 5alpha-dihydroaldosterone and 5alpha-dihydro-11-deoxycorticosterone.
    Sekihara H; Island DP; Liddle GW
    Endocrinology; 1978 Oct; 103(4):1450-2. PubMed ID: 744157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of aldosterone-induced antinatriuresis and kaliuresis by actinomycin D.
    Horisberger JD; Diezi J
    Am J Physiol; 1984 Feb; 246(2 Pt 2):F201-4. PubMed ID: 6696121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestogens with antimineralocorticoid activity.
    Losert W; Casals-Stenzel J; Buse M
    Arzneimittelforschung; 1985; 35(2):459-71. PubMed ID: 4039568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antinatriuretic and kaliuretic effects of the glucocorticoids corticosterone and cortisol following pretreatment with carbenoxolone sodium (a liquorice derivative) in the adrenalectomized rat.
    Souness GW; Morris DJ
    Endocrinology; 1989 Mar; 124(3):1588-90. PubMed ID: 2917528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The possible biological role of aldosterone metabolites.
    Morris DJ; Kenyon CJ; Latif SA; McDermott M; Goodfriend TL
    Hypertension; 1983; 5(2 Pt 2):I35-40. PubMed ID: 6826227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies of the mineralocorticoid activity of 19-oxo-deoxycorticosterone.
    Kenyon CJ; Saccoccio NA; Morris DJ
    Endocrinology; 1984 Aug; 115(2):535-7. PubMed ID: 6745168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal potassium adaptation in the rat: role of glucocorticoids and aldosterone.
    Adam WR; Goland GJ; Wellard RM
    Am J Physiol; 1984 Mar; 246(3 Pt 2):F300-8. PubMed ID: 6703064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependent aldosterone metabolism in toad urinary bladder.
    Brem AS; Pacholski M; Morris DJ
    Am J Physiol; 1988 Apr; 254(4 Pt 2):F547-53. PubMed ID: 3128118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.